Stock pay outran buybacks. Stock-based pay expense $25M vs $20M spent repurchasing shares over the 3 fiscal years to 2025. Shares outstanding changed −1.6% from December 2022 to July 2026.
Over three fiscal years Core Laboratories recorded $25M of stock-based pay expense and spent $20M repurchasing shares (repurchases can include shares withheld to cover employees' taxes). Repurchases were smaller than the stock pay, so they did little to offset new employee shares.Over three fiscal years Core Laboratories recorded $25M of stock-based pay expense and spent $20M repurchasing shares. Repurchases were smaller than the stock pay, so they did little to offset new employee shares.
Profits growing faster than sales. Since 2022: revenue +7.5%, operating profit +36%.
Since 2022, Core Laboratories's revenue grew 7.5% while operating profit grew 36%: each extra dollar of sales is adding more profit.
More volatile share price. Beta 1.14: tends to move more than the market.
Core Laboratories's shares have swung more with the market than most peers' (beta 1.14, above the market's 1.0).
Since last quarter: No major changeValuation also moves with the share price every day.
Why it changed since the Oct 27, 2026 close: Score 40 → 42
Share price -5.4%+4
Company's reported figures updated-1
Peer companies moved-1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Core Laboratories
Is Core Laboratories getting weaker?
Its latest SEC filing (Jul 30, 2026) showed no major changes. Its overall score is unchanged at 42/100 since Oct 28, 2026.
How is Core Laboratories valued vs its peers?
Priced about in line with its peers. Valuation scores 42/100 against 404 energy peers.Free cash flow yield 3.4% vs a peer median of 6.2% (weaker than 68% of peers).Free cash flow yield 3.4% vs peers 6.2% (weaker than 68% of peers).
Is Core Laboratories growing?
At about the same pace as its peers. Growth scores 41/100 against 404 energy peers.Earnings per share growth -16.0% vs a peer median of 1.1% (weaker than 61% of peers).Earnings per share growth -16.0% vs peers 1.1% (weaker than 61% of peers).
How profitable is Core Laboratories?
About as profitable as its peers. Profitability scores 41/100 against 404 energy peers.
How risky is Core Laboratories?
Moderate risk relative to 404 energy peers, judged on debt, liquidity and share-price swings.Current ratio 2.12× vs a peer median of 1.37× (stronger than 76% of peers).Current ratio 2.12× vs peers 1.37× (stronger than 76% of peers).Beta 1.14 vs a peer median of 0.57 (weaker than 90% of peers).Beta 1.14 vs peers 0.57 (weaker than 90% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Jul 30, 2026 · compared with the quarter ended Mar 31, 2026
No major changes
Previous quarter
Latest quarter
Change
Revenue (12 months)
524.7M USD
519.2M USD
−1.1%
Net income (12 months)
29.0M USD
24.4M USD
−16.1%
Operating margin
10.3%
9.2%
−1.1 pts
Free cash flow (12 months)
22.5M USD
15.1M USD
−32.6%
Debt
117.0M USD
116.4M USD
−0.5%
Cash
22.8M USD
22.7M USD
−0.4%
Shares outstanding
46.1M
45.9M
−0.5%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Sector: Energy · 117 companies
Valuations in Energy are above their usual range since 2016.
71% of months since 2016 were valued lower than now.
41% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values +37% and earnings +10% (medians): prices rose faster than earnings.
Median price-to-sales is −30% vs the whole market, against a usual −35%.
2016Shaded: most expensive fifth of its range2026
Shown for Energy: too few Oil & Gas Equipment & Services companies have a long enough history of their own.
This is a cyclical group: after a downturn, trailing earnings and sales fall faster than prices, which can make valuations look high near a cycle's low.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on earnings, EBITDA, sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Change
Gross margin
—
19.6%
21.5%
19.7%
20.7%
▲ 1.0 pts
Operating margin
9.6%
8.5%
10.7%
11.2%
10.7%
▼ 0.5 pts
Net margin
4.2%
4.0%
7.2%
6.0%
5.6%
▼ 0.4 pts
Return on assets (ROA)
3.4%
3.4%
6.3%
5.4%
5.1%
▼ 0.3 pts
Return on equity (ROE)
12.3%
10.6%
16.3%
12.7%
11.2%
▼ 1.6 pts
Free cash flow margin
4.9%
3.0%
2.8%
8.5%
4.9%
▼ 3.6 pts
Current ratio
—
2.05×
2.53×
2.16×
2.02×
▼ 6.3%
Quick ratio
—
1.47×
1.72×
1.58×
1.51×
▼ 4.4%
Debt to equity
—
0.95×
0.74×
0.52×
0.42×
▼ 18%
Interest coverage
4.95×
3.59×
4.07×
4.73×
5.34×
▲ 13%
CLB price history
Price history is added with the daily price update and will appear after the next one.